SK

Sandip Kanti Gayen

Director Director DIN 08630152
DIN 08630152 First appointment Dec 2019 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Dec 2019
Shareholding value β€’β€’β€’β€’ Premium profile

About Sandip Kanti Gayen

Data last updated:

Sandip Kanti Gayen was a Director at Indiglove Pharma Private Limited (2019–2021). The company operates in Pharma.

DIN 08630152
Primary Designation Director
Industry Pharma
First Appointment 05 Dec 2019

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Indiglove Pharma Private Limited U52609WB2019PTC233791
Director05 Dec 20192019₹2.29 Cr (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Indiglove Pharma Private Limited
Premium access

Shareholding and investment profile for Sandip Kanti Gayen

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandip Kanti Gayen

Sandip Kanti Gayen was first appointed on 05 Dec 2019 as Director at Indiglove Pharma Private Limited.

Sandip Kanti Gayen held 1 earlier board appointment: Indiglove Pharma Private Limited (Director, 05 Dec 2019 to 06 Apr 2021).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available